Region:Global
Product Code:GDME0404EPD
Intravascular Ultrasound Systems (IVUS)-Medical Devices Pipeline Assessment, 2017
Summary
GlobalData's Medical Devices sector report, "Intravascular Ultrasound Systems (IVUS)-Medical Devices Pipeline Assessment, 2017" provides an overview of Intravascular Ultrasound Systems (IVUS) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intravascular Ultrasound Systems (IVUS) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Intravascular Ultrasound Systems (IVUS) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Intravascular Ultrasound Systems (IVUS) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to-
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Intravascular Ultrasound Systems (IVUS) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Arbor Ultrasound Technologies, LLC
Biosense Webster Inc
Boston Scientific Corp
Conavi Medical Inc.
Covidien plc
Georgia Institute of Technology
North Carolina State University
OCT Medical Imaging Inc
RadioSon Corporation
SIBUS Medical, Inc.
Soundpipe LLC
Terumo Corp
University of Oxford
University of Texas at Austin
Vesselon Inc
Volcano Corp
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Intravascular Ultrasound Systems (IVUS) Overview 6
3 Products under Development 7
3.1 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Stage of Development 7
3.2 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Segment 8
3.3 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Territory 9
3.4 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Regulatory Path 10
3.5 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Estimated Approval Date 11
4 Intravascular Ultrasound Systems (IVUS)-Pipeline Products under Development by Companies 12
4.1 Intravascular Ultrasound Systems (IVUS) Companies-Pipeline Products by Stage of Development 12
4.2 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Stage of Development 13
5 Intravascular Ultrasound Systems (IVUS) Companies and Product Overview 14
5.1 Arbor Ultrasound Technologies, LLC (Inactive) Company Overview 14
5.1.1 Arbor Ultrasound Technologies, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Biosense Webster Inc Company Overview 15
5.2.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Boston Scientific Corp Company Overview 16
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Conavi Medical Inc. Company Overview 17
5.4.1 Conavi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Covidien plc Company Overview 18
5.5.1 Covidien plc Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Georgia Institute of Technology Company Overview 19
5.6.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 North Carolina State University Company Overview 20
5.7.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 20
5.8 OCT Medical Imaging Inc Company Overview 21
5.8.1 OCT Medical Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.9 RadioSon Corporation Company Overview 22
5.9.1 RadioSon Corporation Pipeline Products & Ongoing Clinical Trials Overview 22
5.10 SIBUS Medical, Inc. Company Overview 23
5.10.1 SIBUS Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.11 Soundpipe LLC Company Overview 24
5.11.1 Soundpipe LLC Pipeline Products & Ongoing Clinical Trials Overview 24
5.12 Terumo Corp Company Overview 25
5.12.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 25
5.13 University of Oxford Company Overview 26
5.13.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 26
5.14 University of Texas at Austin Company Overview 27
5.14.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 27
5.15 Vesselon Inc Company Overview 28
5.15.1 Vesselon Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.16 Volcano Corp Company Overview 29
5.16.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 29
6 Intravascular Ultrasound Systems (IVUS)-Recent Developments 35
6.1 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 35
6.2 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 36
6.3 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 37
6.4 Jun 19, 2017: Conavi Medical Welcomes Peter Wehrly to the Board of Directors 39
6.5 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 40
6.6 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 40
6.7 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 43
6.8 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 44
6.9 Feb 09, 2017: Terumo Announces Change of Executive Officers 47
6.10 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 48
6.11 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 49
6.12 Jan 31, 2017: Terumo Opens a Branch in Yangon 50
6.13 Dec 12, 2016: Terumo Formulates 5-Year Mid-to Long-term Growth Strategy 50
6.14 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 51
6.15 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 54
6.16 Nov 15, 2016: NanoVibronix Provides Third Quarter 2016 Business Update 54
6.17 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 55
6.18 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 56
6.19 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 57
6.20 Oct 20, 2016: NanoVibronix Expands Senior Management Team and Board of Directors 58
6.21 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 59
6.22 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 61
6.23 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 61
6.24 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 62
7 Appendix 66
7.1 Methodology 66
7.2 About GlobalData 69
7.3 Contact Us 69
7.4 Disclaimer 69
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.